The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Proteasomal Degradation of Runx2 Shortens Parathyroid Hormone-induced Anti-apoptotic Signaling in Osteoblasts
Open accessAbstract
It is unknown why sustained elevation of parathyroid hormone (PTH) stimulates bone resorption, whereas intermittent administration stimulates bone formation. We show in mice that daily injections of PTH attenuate osteoblast apoptosis, thereby increasing osteoblast number, bone formation rate, and bone mass, but do not affect osteoclast number. In contrast, sustained elevation of PTH, achieved either by infusion or by raising endogenous hormone secretion with a calcium-deficient diet, does not affect osteoblast apoptosis but increases osteoclast number. Attenuation of apoptosis by PTH in cultured osteoblastic cells requires protein kinase A-mediated phosphorylation and inactivation of the pro-apoptotic protein Bad as well as transcription of survival genes, like Bcl-2, mediated by CREB (cAMP response element-binding protein) and Runx2. But, PTH also increases proteasomal proteolysis of Runx2. Moreover, the anti-apoptotic effect of PTH is prolonged by inhibition of proteasomal activity, by overexpressing a dominant negative form of the E3 ligase (ubiquitin-protein isopeptide ligase) that targets Runx2 for degradation (Smurf1), or by overexpressing Runx2 itself. The duration of the anti-apoptotic effect of PTH, thus, depends on the level of Runx2, which in turn is decreased by PTH via Smurf1-mediated proteasomal proteolysis. The self-limiting nature of PTH-induced survival signaling might explain why intermittent administration of the hormone is required for bone anabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
Glickman, M. H., & Ciechanover, A. (2002) · Physiological Reviews · doi:10.1152/physrev.00027.2001 · Cited by 4,237
Kendall's Advanced Theory of Statistics.
AA, Stuart, A., & Ord, K. (1995) · Journal of the American Statistical Association · doi:10.2307/2291187 · Cited by 2,619
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
Self-citationBAX and BAK Regulation of Endoplasmic Reticulum Ca 2+ : A Control Point for Apoptosis
Scorrano, L., Oakes, S. A., Opferman, J. T., Cheng, E. H., Sorcinelli, M. D., Pozzan, T., & Korsmeyer, S. J. (2003) · Science · doi:10.1126/science.1081208 · Cited by 1,385
Belchetz, P. E., Plant, T. M., Nakai, Y., Keogh, E. J., & Knobil, E. (1978) · Science · doi:10.1126/science.100883 · Cited by 1,385
Transformation of Mammalian Cells by Constitutively Active MAP Kinase Kinase
Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., Fukasawa, K., Vande Woude, G. F., & Ahn, N. G. (1994) · Science · doi:10.1126/science.8052857 · Cited by 1,353
Bone histomorphometry : techniques and interpretation
Recker, R. R. (1983) · CRC Press eBooks · Cited by 1,158
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,113
Self-citationIncreased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
Self-citationBone and haematopoietic defects in mice lacking c-fos
Wang, Z.-Q., Ovitt, C., Grigoriadis, A. E., Möhle-Steinlein, U., Rüther, U., & Wagner, E. F. (1992) · Nature · doi:10.1038/360741a0 · Cited by 934
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890
Self-citationA SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation
Zhu, H., Kavsak, P., Abdollah, S., Wrana, J. L., & Thomsen, G. H. (1999) · Nature · doi:10.1038/23293 · Cited by 845
A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development
Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G., Geoffroy, V., Amling, M., & Karsenty, G. (1999) · Genes & Development · doi:10.1101/gad.13.8.1025 · Cited by 774
Anabolic Actions of Parathyroid Hormone on Bone*
DEMPSTER, D. W., COSMAN, F., PARISIEN, M., SHEN, V., & LINDSAY, R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-6-690 · Cited by 717
14-3-3 Proteins and Survival Kinases Cooperate to Inactivate BAD by BH3 Domain Phosphorylation
Datta, S. R., Katsov, A., Hu, L. S., Petros, A. M., Fesik, S. W., Yaffe, M. B., & Greenberg, M. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00006-x · Cited by 663
Dobnig, H. (1995) · Endocrinology · doi:10.1210/en.136.8.3632 · Cited by 615
(2002) · Elsevier eBooks · doi:10.1016/b978-0-12-098652-1.x5100-2 · Cited by 591
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.793 · Cited by 578
Self-citationAhn, S., Olive, M., Aggarwal, S., Krylov, D., Ginty, D. D., & Vinson, C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.967 · Cited by 503
High Bone Mass in Mice Expressing a Mutant LRP5 Gene
Babij, P., Zhao, W., Small, C., Kharode, Y., Yaworsky, P. J., Bouxsein, M. L., Reddy, P. S., Bodine, P. V., Robinson, J. A., Bhat, B., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.960 · Cited by 497
Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2.
Lecka‐Czernik, B., Gubrij, I. B., Moerman, E. J., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., & Jilka, R. L. (1999) · PubMed · Cited by 464
Self-citationThe ubiquitin‐proteasome pathway and proteasome inhibitors
Myung, J., Kim, K. B., & Crews, C. M. (2001) · Medicinal Research Reviews · doi:10.1002/med.1009 · Cited by 446
Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids
Kousteni, S., Chen, J.-R., Bellido, T., Han, L., Ali, A. A., O'Brien, C. A., Plotkin, L., Fu, Q., Mancino, A. T., Wen, Y., et al. (2002) · Science · doi:10.1126/science.1074935 · Cited by 420
Self-citationWilson, B. E., Mochon, E., & Boxer, L. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5546 · Cited by 410
Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR?2
Lecka-Czernik, B., Gubrij, I., Moerman, E. J., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., & Jilka, R. L. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990901)74:3<357::aid-jcb5>3.0.co;2-7 · Cited by 405
Self-citationParathyroid hormone-dependent signaling pathways regulating genes in bone cells
Swarthout, J. T., D'Alonzo, R. C., Selvamurugan, N., & Partridge, N. C. (2002) · Gene · doi:10.1016/s0378-1119(01)00798-3 · Cited by 340
Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118600 · Cited by 339
Self-citationDobnig, H. (1997) · Endocrinology · doi:10.1210/en.138.11.4607 · Cited by 322
Weinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214538 · Cited by 313
Self-citationPathogenesis of secondary hyperparathyroidism
Slatopolsky, E., Brown, A., & Dusso, A. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07304.x · Cited by 309
Amling, M., Neff, L., Tanaka, S., Inoue, D., Kuida, K., Weir, E., Philbrick, W. M., Broadus, A. E., & Baron, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.1.205 · Cited by 304
Zhao, M., Qiao, M., Oyajobi, B. O., Mundy, G. R., & Chen, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304132200 · Cited by 279
Dominant Negative Stat3 Mutant Inhibits Interleukin-6-induced Jak-STAT Signal Transduction
Kaptein, A., Paillard, V., & Saunders, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.5961 · Cited by 245
Fu, Q., Jilka, R. L., Manolagas, S. C., & O'Brien, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208494200 · Cited by 227
Self-citationGrowth Factors Inactivate the Cell Death Promoter BAD by Phosphorylation of Its BH3 Domain on Ser155
Zhou, X.-M., Liu, Y., Payne, G., Lutz, R. J., & Chittenden, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002526200 · Cited by 225
Arresting developments in heptahelical receptor signaling and regulation
Perry, S. J., & Lefkowitz, R. J. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02239-5 · Cited by 218
Mechanism of action of a dominant-negative mutant of c-Jun.
Brown, P. H., Chen, T. K., & Birrer, M. J. (1994) · PubMed · Cited by 205
A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo1
Grey, A., Mitnick, M.-A., Masiukiewicz, U., Sun, B.-H., Rudikoff, S., Jilka, R. L., Manolagas, S. C., & Insogna, K. (1999) · Endocrinology · doi:10.1210/endo.140.10.7036 · Cited by 163
Self-citationDuan, R., Xie, W., Burghardt, R. C., & Safe, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005492200 · Cited by 162
Parathyroid Hormone Bone Anabolic Action Requires Cbfa1/Runx2-Dependent Signaling
Krishnan, V., Moore, T. L., Ma, Y. L., Helvering, L. M., Frolik, C. A., Valasek, K. M., Ducy, P., & Geiser, A. G. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0225 · Cited by 162
Guo, C. Y. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3487 · Cited by 159
Kondo, H., Guo, J., & Bringhurst, F. R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.9.1667 · Cited by 158
Tintut, Y., Parhami, F., Le, V., Karsenty, G., & Demer, L. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28875 · Cited by 151
Parathyroid Hormone and Periosteal Bone Expansion
PARFITT, A. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.10.1741 · Cited by 146
Taylor, C. T., Furuta, G. T., Synnestvedt, K., & Colgan, S. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220211797 · Cited by 134
Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats
Wronski, T. J., & Yen, C. ‐. (1994) · Bone · doi:10.1016/8756-3282(94)90891-5 · Cited by 131
Podos, S. D., Hanson, K. K., Wang, Y., & Ferguson, E. L. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00057-0 · Cited by 120
Leaffer, D., Sweeney, M., Kellerman, L., et al. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628402 · Cited by 116
Principles of Molecular Regulation
Conn, P. M., & Means, A. R. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-032-2 · Cited by 65
Synthetic peptide-based activators of the proteasome
Wilk, S., & Chen, W. (1997) · Molecular Biology Reports · doi:10.1023/a:1006851428691 · Cited by 37
Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cells
Cheng, Z., Adi, S., Wu, N., Hsiao, D., Woo, E., Filvaroff, E. H., Gustafson, T. A., & Sm, R. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670175 · Cited by 28
Arora, K., & Warrior, R. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00067-3 · Cited by 25
Pompeiano, M., Hvala, M., & Chun, J. J. M. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400403 · Cited by 22
Cellular Actions of Parathyroid Hormone on Osteoblast and Osteoclast Differentiation
Aubin, J. E., & Heersche, J. N. M. (2001) · Elsevier eBooks · doi:10.1016/b978-012098651-4/50014-6 · Cited by 20
Cited by
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Jilka, R. L. (2007) · Bone · doi:10.1016/j.bone.2007.03.017 · Cited by 720
Self-citationBellido, T., Ali, A. A., Gubrij, I., Plotkin, L. I., Fu, Q., O’Brien, C. A., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2005-0239 · Cited by 641
Self-citationParathyroid hormone: anabolic and catabolic actions on the skeleton
Silva, B. C., & Bilezikian, J. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.03.005 · Cited by 557
Networks and hubs for the transcriptional control of osteoblastogenesis
Lian, J. B., Stein, G. S., Javed, A., van Wijnen, A. J., Stein, J. L., Montecino, M., Hassan, M. Q., Gaur, T., Lengner, C. J., & Young, D. W. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9001-5 · Cited by 468
Rosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation
Ali, A. A., Weinstein, R. S., Stewart, S. A., Parfitt, A. M., Manolagas, S. C., & Jilka, R. L. (2005) · Endocrinology · doi:10.1210/en.2004-0735 · Cited by 444
Self-citation
Metadata
- Authors
- Bellido, T., Ali, A. A., Plotkin, L. I., Fu, Q., Gubrij, I., Roberson, P. K., Weinstein, R. S., O'Brien, C. A., Manolagas, S. C., & Jilka, R. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 278
- Issue
- 50
- Pages
- 50259-50272
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1968677875
- Cited by
- 378
- References
- 56
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.